On October 1, 2024, Director William Carson purchased 3,200 shares of Annexon Inc (ANNX, Financial), as reported in a recent SEC Filing. The transaction occurred at a price of $5.97 per share, totaling $19,104. Following this transaction, the insider now owns 22,400 shares of the company.Annexon Inc focuses on the development of therapeutics for autoimmune and neurodegenerative disorders. The company's approach targets the classical complement pathway to prevent abnormal activation, which is a cause of thes ...